Skip to Content

MagForce AG MGFRF

Morningstar Rating
$0.00 0.00 (150.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MGFRF is trading at a 832% premium.
Price
$0.00
Fair Value
$4.54
Uncertainty
Extreme
1-Star Price
$7.88
5-Star Price
$9.68
Economic Moat
Qkcq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MGFRF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
/
Market Cap
$29,931.74
Volume/Avg
1,800 / 1,017

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

MagForce AG is a medical engineering company. The company operates in the area of nanotechnology-based cancer treatment. Its medical devices include NanoTherm therapy used for local treatment of solid tumors, NanoTherm a liquid that reacts to the presence of a magnetic field, NanoPlan uses the bioheat transfer equation, and NanoActivator used for tumors in all areas of the body.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
69

Valuation

Metric
MGFRF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
MGFRF

Financial Strength

Metric
MGFRF
Quick Ratio
0.12
Current Ratio
0.19
Interest Coverage
−2.67
Quick Ratio
MGFRF

Profitability

Metric
MGFRF
Return on Assets (Normalized)
−15.02%
Return on Equity (Normalized)
−31.05%
Return on Invested Capital (Normalized)
−13.79%
Return on Assets
MGFRF
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
PqgqzvsdLllgzc$177.5 Bil
Stryker Corp
SYK
FndtklshgXytx$129.9 Bil
Boston Scientific Corp
BSX
WrybtxwvvZvqgxh$114.0 Bil
Medtronic PLC
MDT
RtvhpbvhfGztbbp$101.9 Bil
Edwards Lifesciences Corp
EW
CdsbbswvmVmdvsb$52.1 Bil
DexCom Inc
DXCM
XppcktpgtDql$44.2 Bil
Koninklijke Philips NV ADR
PHG
RwccbgxyqGkrpgjh$24.3 Bil
Zimmer Biomet Holdings Inc
ZBH
PzqstgxxPlfs$22.7 Bil
Steris PLC
STE
PlqfrhhtqCtzmh$22.2 Bil
Align Technology Inc
ALGN
PjtnnpmbPcslf$18.9 Bil

Sponsor Center